| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531555 | International Immunopharmacology | 2018 | 10 Pages |
Abstract
MiR-150-5p and its identified target, EGR2, are involved in the development of CRS. DCs can promote T cell proliferations of peripheral blood in CRS.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Zuxia Ma, Yang Shen, Quan Zeng, Jie Liu, Li Yang, Ran Fu, Guohua Hu,